174 related articles for article (PubMed ID: 25339385)
1. [Anti-p200/anti-laminin γ1 pemphigoid and BP180 NC16A/4575- positive mucous membrane pemphigoid : late diagnosis in a patient with disease-related loss of vision and multiple previous surgical interventions].
Kaune KM; Kasperkiewicz M; Tams D; Bergmann M; Zutt M
Hautarzt; 2015 Jan; 66(1):60-4. PubMed ID: 25339385
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of pemphigus herpetiformis with IgG antibodies to desmocollin 1 and pemphigoid with IgG antibodies to BP180 C-terminal domain and laminin γ2.
Ohata C; Higashi Y; Yamagami J; Koga H; Ishii N; Kanekura T; Furumura M; Hashimoto T
JAMA Dermatol; 2013 Apr; 149(4):502-4. PubMed ID: 23715433
[No Abstract] [Full Text] [Related]
3. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
[TBL] [Abstract][Full Text] [Related]
4. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
5. Case of subepidermal autoimmune bullous disease with psoriasis vulgaris reacting to both BP180 C-terminal domain and laminin gamma-1.
Ishida S; Takahashi K; Kanaoka M; Okawa T; Tateishi C; Yasukochi A; Ishii N; Li X; Hashimoto T; Aihara M
J Dermatol; 2015 Apr; 42(4):391-3. PubMed ID: 25683229
[TBL] [Abstract][Full Text] [Related]
6. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.
Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T
Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276
[No Abstract] [Full Text] [Related]
7. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
8. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
9. Anti-BP180-type oral mucous membrane pemphigoid reactive to both NC16a and C-terminal domains.
Uchiyama M; Mitsuhashi Y; Tsuboi R; Ishii N; Hayakawa T; Yasukochi A; Hashimoto T
Indian J Dermatol Venereol Leprol; 2015; 81(6):637-9. PubMed ID: 26515855
[No Abstract] [Full Text] [Related]
10. Clinical and Immunological Studies of 332 Japanese Patients Tentatively Diagnosed as Anti-BP180-type Mucous Membrane Pemphigoid: A Novel BP180 C-terminal Domain Enzyme-linked Immunosorbent Assay.
Yasukochi A; Teye K; Ishii N; Hashimoto T
Acta Derm Venereol; 2016 Aug; 96(6):762-7. PubMed ID: 26984589
[TBL] [Abstract][Full Text] [Related]
11. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
[TBL] [Abstract][Full Text] [Related]
12. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
[TBL] [Abstract][Full Text] [Related]
13. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.
Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H
Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184
[TBL] [Abstract][Full Text] [Related]
14. Detection of mucous membrane pemphigoid autoantibodies by full-length BP180 enzyme-linked immunosorbent assay.
Izumi K; Nishie W; Mai Y; Ujiie H; Iwata H; Natsuga K; Shimizu H
J Dermatol Sci; 2017 Nov; 88(2):247-248. PubMed ID: 28736219
[No Abstract] [Full Text] [Related]
15. Four cases of mucous membrane pemphigoid with clinical features of oral lichen planus.
Fukuda A; Himejima A; Tsuruta D; Koga H; Ohyama B; Morita S; Hashimoto T
Int J Dermatol; 2016 Jun; 55(6):657-65. PubMed ID: 26341508
[TBL] [Abstract][Full Text] [Related]
16. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
17. [Anti-laminin 332 mucous membrane pemphigoid with irreversible ocular and tracheobronchial involvement : Delayed diagnosis of a severe autoimmune bullous disease].
Syring FM; Zillikens D; Schmidt E; Kasperkiewicz M
Hautarzt; 2019 May; 70(5):367-370. PubMed ID: 30963224
[TBL] [Abstract][Full Text] [Related]
18. Case of pemphigoid with immunoglobulin G antibodies to BP180 C-terminal domain and laminin-γ1 (p200) developed after pneumococcal vaccination.
Maki N; Hashimoto T; Yamada T; Ishii N; Tsuruta D; Demitsu T
J Dermatol; 2021 Jan; 48(1):101-105. PubMed ID: 32974956
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients.
Di Zenzo G; Grosso F; Terracina M; Mariotti F; De Pità O; Owaribe K; Mastrogiacomo A; Sera F; Borradori L; Zambruno G
J Invest Dermatol; 2004 Jan; 122(1):103-10. PubMed ID: 14962097
[TBL] [Abstract][Full Text] [Related]
20. A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin.
Aoki N; Nakajima K; Shiga T; Koga H; Hashimoto T; Sano S
J Dermatol; 2014 Jun; 41(6):557-9. PubMed ID: 24909219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
